Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing Type 2 (non-insulin-dependent) diabetes mellitus
- 1 March 1992
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 35 (3), 291-293
- https://doi.org/10.1007/bf00400933
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- In Vivo Insulin Resistance Induced by Amylin Primarily Through Inhibition of Insulin-Stimulated Glycogen Synthesis in Skeletal MuscleDiabetes, 1991
- Slow Glucose Removal Rate and Hyperinsulinemia Precede the Development of Type II Diabetes in the Offspring of Diabetic ParentsAnnals of Internal Medicine, 1990
- Regional distribution and molecular forms of rat islet amyloid polypeptideBiochemical and Biophysical Research Communications, 1990
- Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogsDiabetologia, 1990
- Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in manDiabetologia, 1990
- Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- IMPAIRED GLUCOSE-TOLERANCE IS ASSOCIATED WITH INCREASED ISLET AMYLOID POLYPEPTIDE (IAPP) IMMUNOREACTIVITY IN PANCREATIC BETA-CELLS1989
- Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1989
- Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitroNature, 1988